NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

They have not lost their gamble. The publication and relevant press coverage has not yet occurred that that was based on. The NYAS and subsequent scientific presentation could not possibly have that affect. No one knows about them.

So the only reason I see for the NYAS presentation is that they needed to validate a deal or offer they have already, but letting the very narrowly focused world of scientists know their results just previous to ASCO and to see if they have other deals. Now they may not accept any deals at this stage, they may still be too low. But I do not believe the NYAS presentation was the relevant event intended to pop the price. I think they did hope it would probably get it back to the $1.50-$2.00 range, where it had been for lesser reasons.

Shorts and AF dashed that, but I do not think that was part of the original plan.